ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

Assumption, Not Facts Form Base For Regulation Of Carcinogens, One Regulatory Coucil consultant Says; request for Study By NSA Denied

June 8, 1979

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

September 11, 1992